Who can apply?
Please make sure to check the eligibility criteria before submitting your project!
Project Submission page
Submit your project through the online submission tool available here below. We recommend to use Google Chrome when uploading your project.
Please be informed you will need to create a user profile before being able to submit your project. Once you have created your user profile, you will be able to submit your project.
Useful tip!
You will be able to start and save your project and submit it a a later stage when your project is totally finalised.
Deadline
- Project Submission Deadline: 4 December 2023, midnight (CET)
Participation requirements AMGINY Award 2024
Who can apply?
The candidate must fulfill all criteria below:
- be a member of BHS and a natural person
- Young hematologists (<35 years) or hematologists in training who are MD and are within 10 years after MD graduation
- may not be an employee of the pharmaceutical industry
Which projects are eligible?
- Innovative projects which are dedicated to enhancing patient care (e.g. screening, diagnosis, treatment decision-making, and follow-up) by leveraging advanced technologies. The rapid advancement of artificial intelligence (AI) and big data analytics has opened new avenues for transforming healthcare and improving patient outcomes. Therefore, projects utilising AI or big data are of particular interest.
- Projects should be carried out in the hospital or outpatient setting (but with a link to the hospital).
- The project must not be directly linked to the use of a specific pharmaceutical specialty.
- The project must be carried out in compliance with the Protection of Privacy Law.
Application requirements?
The application must preferably be written in English* and must consist of :
- a description of the different project members and including the curriculum vitae of the applicant
- a detailed project form with a maximum of 3 pages including a budget estimate and time frame Detailed project form AMGINY award 2024.docx
- a summary in abstract format with a maximum of 2500 characters (including spaces) for possible publication in the Belgian Journal of Hematology
* applications in French or Dutch are acceptable, but the abstract/summary must be in English
Evaluation criteria:
- relevance and impact of the project in the improvement of patient care (50%)
- originality of the project in terms of the proposed theme (25%)
- feasibility of the project (20%)
- relevance of the budgetary estimate (5%)
Only submission through the online form is possible. Submissions sent by e-mail will not be considered.
AMGINY Award
A prize award of 20.000 euros will be given to the winner.
Please note, the prize money cannot be allocated to fund a salary, but it can cover activity and material costs.
The winner of the AMGINY Award will be announced during the 2024 General Annual Meeting of the BHS.
The BHS AMGINY award has been made possible with an unrestricted grant from Amgen.